MEDP in the 13F filings
Medpace HLDGS Inc · CUSIP 58506Q109
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 8 May 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 12 listed it in both
- Shares listed
- 4,948,558
- combined, among listed positions
- Reported value
- $2.4bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 12 buyers (opened or added shares) and 21 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +21,531.
Managers listing MEDP in Q1 2026
30 of 30 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 289,507 shares now+172,926
- Two Sigma Investments LPexisting position · 176,557 shares now+119,176
- Invesco Ltdexisting position · 577,574 shares now+94,949
- Balyasny Asset Management LLCnew position · 42,293 shares now+42,293
- Renaissance Technologies LLCexisting position · 504,668 shares now+38,760
Reductions
- D. E. Shaw & Co.existing position · 432,602 shares now-95,630
- Tudor Investment Corpexisting position · 8,699 shares now-80,543
- Voloridge Investment Management LLCexisting position · 74,730 shares now-64,631
- Citadel Advisors LLCexisting position · 808 shares now-58,932
- Millennium Management LLCexisting position · 5,676 shares now-46,315
New positions and exits
New (1)
Exited (4)
- ExodusPoint Capital Management LPwas $1.5m
- Brevan Howard Capital Management LPwas $1.1m
- Polen Capital Management LLCwas $391k
- Winton Group Ltdwas $269k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2017 | 2 | $21m | n.a. | n.a. |
| Q2 2017 | 1 | $14m | n.a. | n.a. |
| Q3 2017 | 1 | $19m | n.a. | n.a. |
| Q4 2017 | 1 | $23m | n.a. | n.a. |
| Q1 2018 | 3 | $37m | n.a. | n.a. |
| Q2 2018 | 4 | $59m | n.a. | n.a. |
| Q3 2018 | 14 | $247m | n.a. | n.a. |
| Q4 2018 | 6 | $119m | n.a. | n.a. |
| Q1 2019 | 4 | $100m | n.a. | n.a. |
| Q2 2019 | 4 | $117m | n.a. | n.a. |
| Q3 2019 | 6 | $140m | n.a. | n.a. |
| Q4 2019 | 5 | $122m | n.a. | n.a. |
| Q1 2020 | 7 | $144m | n.a. | n.a. |
| Q2 2020 | 8 | $173m | n.a. | n.a. |
| Q3 2020 | 12 | $218m | n.a. | n.a. |
| Q4 2020 | 8 | $187m | n.a. | n.a. |
| Q1 2021 | 9 | $153m | n.a. | n.a. |
| Q2 2021 | 8 | $156m | n.a. | n.a. |
| Q3 2021 | 11 | $413m | n.a. | n.a. |
| Q4 2021 | 12 | $668m | n.a. | n.a. |
| Q1 2022 | 6 | $107m | n.a. | n.a. |
| Q2 2022 | 5 | $97m | n.a. | n.a. |
| Q3 2022 | 3 | $59m | n.a. | n.a. |
| Q4 2022 | 10 | $269m | n.a. | n.a. |
| Q1 2023 | 14 | $275m | n.a. | n.a. |
| Q2 2023 | 17 | $468m | n.a. | n.a. |
| Q3 2023 | 15 | $378m | n.a. | n.a. |
| Q4 2023 | 14 | $501m | 8 | 7 |
| Q1 2024 | 17 | $1.2bn | 9 | 8 |
| Q2 2024 | 18 | $1.3bn | 9 | 9 |
| Q3 2024 | 15 | $918m | 9 | 6 |
| Q4 2024 | 15 | $1.2bn | 9 | 6 |
| Q1 2025 | 12 | $986m | 11 | 1 |
| Q2 2025 | 14 | $1.2bn | 12 | 3 |
| Q3 2025 | 17 | $1.9bn | 9 | 8 |
| Q4 2025 | 14 | $2.1bn | 14 | 21 |
| Q1 2026 | 12 | $1.8bn | 12 | 21 |
| Q2 2026 | 9 | $2.7bn | 8 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MEDP and LLY →MEDP and JNJ →MEDP and VRTX →Choose a stock to compare with MEDP →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MEDP, latest filings →Back to the 13F Explorer →